Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
News|Articles|August 10, 2017
What Country Ranks Highest in Pharma Manufacturing?
Author(s)Pharmaceutical Technology Editors
CPhI survey seeks industry input to rank top-performing nations on pharma manufacturing and business factors.
Advertisement
CPhI Worldwide, a sister company to Pharmaceutical Technology, is conducting a global ranking of the top 10 pharmaceutical countries to assess reputations in API production, finished dosage formulations, growth potential, innovation, regulatory acumen, and other factors.
The survey invites participants to share opinions about the performance and reputations of the United Kingdom, France, Italy, Germany, India, the United States, Japan, China, Korea, and Spain. The survey also measures market competitiveness, business growth, transparency, and pharma knowledge.
The insights provided from the survey will build a global picture of the state and strength of the international pharma industry, the survey sponsors report. Individual responses to the survey are anonymous. A summary of the compiled results will be available on
Pharma industry professionals are invited to take the 12-minute survey via this
Please take the survey here:
Advertisement
Related to this article
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement